Good morning

Eugia Pharma Receives USFDA Approval for Olanzapine for Injection 10 mg Single-Dose Vials

Published: October 22, 2020

Eugia Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Olanzapine for Injection, 10 mg/vial, Single-dose Vials.

Indications for this product include:

  • Acute agitation associated with schizophrenia and bipolar I mania.

Refer to package insert for full prescribing information including Boxed Warning.